Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OXTR | P30559 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA5A | P35218 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrogen Sulfide SCHEMBL160308 | 1.00 | — | — | |
| Hydrogen Sulfide SCHEMBL11443781 | 1.00 | OXTR (0.50) | OXTRCA1CA2CA5ACA9 | |
| Hydrogen Sulfide SCHEMBL115631 | 1.00 | — | — | |
| Hydrogen Sulfide SCHEMBL2413702 | 1.00 | — | — | |
| Hydrogen Sulfide SCHEMBL10480737 | 1.00 | — | — | |
| Hydrogen Sulfide SCHEMBL11129259 | 1.00 | — | — | |
| Hydrogen Sulfide SCHEMBL29062664 | 1.00 | — | — | |
| Hydrogen Sulfide SCHEMBL28652062 | 1.00 | — | — | |
| Hydrogen Sulfide SCHEMBL8635477 | 1.00 | — | — | |
| Hydrogen Sulfide SCHEMBL414492 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007001399-A2 | COMPOSITIONS, SPLICE VARIANTS AND METHODS RELATING TO CANCER SPECIFIC GENES AND PROTEINS | DIADEXUS, INC. (US) | 2007-01-04 | — | — | WO | disclosed |
| WO-2006121991-A2 | COMPOSITIONS AND METHODS FOR DETECTION, PROGNOSIS AND TREATMENT OF BREAST CANCER | DIADEXUS, INC. (US) | 2006-11-16 | — | — | WO | disclosed |
| EP-1581641-A4 | COMPOSITIONS, SPLICE VARIANTS AND METHODS RELATING TO OVARIAN SPECIFIC GENES AND PROTEINS | DIADEXUS INC (US) | 2006-11-15 | — | — | EP | disclosed |
| EP-1581641-A2 | COMPOSITIONS, SPLICE VARIANTS AND METHODS RELATING TO OVARIAN SPECIFIC GENES AND PROTEINS | Diadexus, Inc. (US) | 2005-10-05 | — | — | EP | disclosed |
| WO-2005044075-A2 | COMPOSITIONS, SPLICE VARIANTS AND METHODS RELATING TO BREAST SPECIFIC GENES AND PROTEINS | DIADEXUS, INC. (US) | 2005-05-19 | — | — | WO | disclosed |
| WO-2005044977-A2 | COMPOSITIONS, SPLICE VARIANTS AND METHODS RELATING TO LUNG SPECIFIC GENES AND PROTEINS | DIADEXUS, INC. (US) | 2005-05-19 | — | — | WO | disclosed |
| WO-2005027713-A2 | COMPOSITIONS, SPLICE VARIANTS AND METHODS RELATING TO COLON SPECIFIC GENES AND PROTEINS | DIADEXUS, INC. (US) | 2005-03-31 | — | — | WO | disclosed |
| WO-2005017102-A2 | COMPOSITIONS, SPLICE VARIANTS AND METHODS RELATING TO OVARIAN SPECIFIC NUCLEIC ACIDS AND PROTEINS | DIADEXUS, INC. (US) | 2005-02-24 | — | — | WO | disclosed |
| WO-2005001049-A2 | COMPOSITIONS, SPLICE VARIANTS AND METHODS RELATING TO OVARIAN SPECIFIC GENES AND PROTEINS | DIADEXUS, INC. (US) | 2005-01-06 | — | — | WO | disclosed |
| WO-2004092338-A2 | COMPOSITIONS, SPLICE VARIANTS AND METHODS RELATING TO CANCER SPECIFIC GENES AND PROTEINS | DIADEXUS, INC. (US) | 2004-10-28 | — | — | WO | disclosed |
| WO-2003059927-A1 | COMPOSITIONS AND METHODS RELATING TO ENDOMETRIAL SPECIFIC GENES AND PROTEINS | DIADEXUS, INC. (US) | 2003-07-24 | — | — | WO | disclosed |
| WO-2003060145-A2 | COMPOSITIONS AND METHODS RELATING TO PANCREATIC SPECIFIC GENES AND PROTEINS | DIADEXUS, INC. (US) | 2003-07-24 | — | — | WO | disclosed |
| WO-2003057839-A2 | COMPOSITIONS AND METHODS RELATING TO URINARY SPECIFIC GENES AND PROTEINS | DIADEXUS, INC. (US) | 2003-07-17 | — | — | WO | disclosed |
| WO-2003055982-A2 | COMPOSITIONS AND METHODS RELATING TO ENDOMETRIAL SPECIFIC GENES AND PROTEINS | DIADEXUS, INC. (US) | 2003-07-10 | — | — | WO | disclosed |
| WO-2003020901-A2 | COMPOSITIONS AND METHODS RELATING TO PROSTATE SPECIFIC GENES AND PROTEINS | DIADEXUS, INC. (US) | 2003-03-13 | — | — | WO | disclosed |
| WO-2003020899-A2 | COMPOSITIONS AND METHODS RELATING TO LUNG SPECIFIC GENES AND PROTEINS | DIADEXUS, INC. (US) | 2003-03-13 | — | — | WO | disclosed |
| WO-2003020953-A2 | COMPOSITIONS AND METHODS RELATING TO COLON SPECIFIC GENES AND PROTEINS | DIADEXUS, INC. (US) | 2003-03-13 | — | — | WO | disclosed |
| WO-2003020934-A1 | COMPOSITIONS AND METHODS RELATING TO COLON SPECIFIC GENES AND PROTEINS | DIADEXUS, INC. (US) | 2003-03-13 | — | — | WO | disclosed |
| WO-2003020900-A2 | COMPOSITIONS AND METHODS RELATING TO BREAST SPECIFIC GENES AND PROTEINS | DIADEXUS, INC. (US) | 2003-03-13 | — | — | WO | disclosed |
| WO-2003020897-A2 | COMPOSITIONS AND METHODS RELATING TO OVARY SPECIFIC GENES AND PROTEINS | DIADEXUS, INC. (US) | 2003-03-13 | — | — | WO | disclosed |